Importantly, Rybelsus is not FDA-approved for chronic weight management and should not be used for weight loss
Minor redness, bruising, or temporary soreness at the injection site is normal and typically resolves within hours
European Medicines Agency approval of oral Wegovy expected 2H 2026 Novo is positioning Ireland as a core manufacturing backbone for its expanding oral GLP-1 franchise
Available from: [accessed 8 August 2025]
Plaintiffs contend that Eli Lilly did not provide adequate warnings about the potential severity and persistence of these complications, while the manufacturer disputes causation and raises case-specific defenses
Our comprehensive evaluation determines whether semaglutide, under the brand names Wegovy, Ozempic and Rybelsus, aligns with your weight loss aspirations